Impact of cardiac rehabilitation on cardiovascular outcomes in patients with coronary artery disease following percutaneous coronary intervention: a meta-analysis

心脏康复对经皮冠状动脉介入治疗后冠状动脉疾病患者心血管结局的影响:一项荟萃分析

阅读:1

Abstract

BACKGROUND: As of 2025, cardiovascular disease (CVD) still remains a major threat to human life. Acute coronary syndrome (ACS) is still considered life-threatening and therefore prompt diagnosis and immediate interventions are mandatory. Nowadays, cardiac rehabilitation (CR) has shown to improve patients' outcomes following cardiac intervention. In this analysis, we aimed to show the impact of CR on cardiovascular outcomes in patients with coronary artery disease following percutaneous coronary intervention (PCI). METHODS: Studies which compared the cardiovascular outcomes in participants who were assigned to a CR group versus a control group following PCI were searched from electronic data sources. The cardiovascular outcomes were the main endpoints in this analysis. Statistical analysis was carried out by the Revman software. Risks ratios (RR) with 95% confidence intervals (CIs) were used to represent and describe the results following analysis. RESULTS: Fifteen studies with a total number of 115,177 participants were included (38,433 participants were assigned to the CR group and 76,744 participants were assigned to a control group). Our results showed major adverse cardiac events (MACEs) and all-cause mortality to be significantly lower in the CR group with (RR: 0.90, 95% CI: 0.81 - 1.00; P = 0.05) and (RR: 0.69, 95% CI: 0.57 - 0.84; P = 0.0002) respectively. In addition, the risks of heart failure (RR: 0.61, 95% CI: 0.49 - 0.76; P = 0.0001), stable and unstable angina (RR: 0.30, 95% CI: 0.18 - 0.49; P = 0.00001) and arrhythmia (RR: 0.70, 95% CI: 0.61 - 0.81; P = 0.00001) were also significantly lower in the CR group. However, re-stenosis, cardiac death, and recurrent myocardial infarction were similarly manifested. CONCLUSION: Our analysis demonstrated that CR post-PCI could have a positive impact on the adverse cardiovascular outcomes whereby MACEs, all-cause mortality and heart failure were significantly decreased. However, due to the several major limitations of this analysis, future larger trials should confirm our hypothesis.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。